Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  Novo Nordisk A/S    NOVO B   DK0060534915

NOVO NORDISK A/S

(NOVO B)
  Report
Real-time Estimate Quote. Real-time Estimate CHI-X - 10/21 03:55:19 am
448.175 DKK   -0.63%
10/16NOVO NORDISK : Buy rating from Goldman Sachs
MD
10/14NOVO NORDISK : Buy rating from JP Morgan
MD
10/12NOVO NORDISK : Credit Suisse gives a Buy rating
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations
Communiqués de presse de la société NOVO NORDISK A/S
10/12NOVO NORDISK A/S : Bavarian Nordic Announces Appointment of Anu Helena Kerns as ..
AQ
10/12NOVO NORDISK A/S : Conference call regarding updated 2020 outlook 9 October 2020
PU
10/12NOVO NORDISK A/S : Alexander Mann Solutions partners with Novo Nordisk to suppor..
AQ
10/12NOVO NORDISK A/S : – Share repurchase programme
AQ
10/08NOVO NORDISK A/S : raises sales and operating profit outlook for 2020
AQ
10/08Novo Nordisk raises sales and operating profit outlook for 2020
GL
09/28NOVO NORDISK A/S : – Share repurchase programme
AQ
09/23NOVO NORDISK A/S : - Switching to investigational once-weekly insulin icodec fro..
AQ
09/22NOVO NORDISK A/S : Switching to investigational once-weekly insulin icodec from ..
PU
09/21NOVO NORDISK A/S : launches new 100% renewable power target for suppliers
AQ
09/21NOVO NORDISK A/S : launches new 100% renewable power target for suppliers
PU
09/14NOVO NORDISK A/S : – Share repurchase programme
AQ
09/01NOVO NORDISK A/S : insulin production line launches in Iran
AQ
08/31NOVO NORDISK A/S : – Share repurchase programme
AQ
08/26NOVO NORDISK A/S : Disclosure of transaction data related to Novo Nordisk's shar..
PU
08/25NOVO NORDISK A/S : Karolinska Institutet, St. Erik Eye Hospital and Novo Nordisk..
AQ
08/20NOVO NORDISK A/S : Q2 2020 conference call presentation
PU
08/20NOVO NORDISK A/S : Q2 2020 London presentation
PU
08/17NOVO NORDISK A/S : Disclosure of transaction data
PU
08/17NOVO NORDISK A/S : – Share repurchase programme
AQ
08/14NOVO NORDISK A/S : Covid-19 - Novo Nordisk Donates PPE to 12 Hospitals
AQ
08/14NOVO NORDISK A/S : resumes the phase 3 clinical trials investigating concizumab
AQ
08/14NOVO NORDISK A/S : resumes the phase 3 clinical trials investigating concizumab ..
AQ
08/14NOVO NORDISK A/S : invests DKK 850 million in production facilities in Kalundbor..
PU
08/14NOVO NORDISK A/S : resumes the phase 3 clinical trials investigating concizumab ..
PU
08/07NOVO NORDISK : 2Q Earnings Snapshot
AQ
08/06Novo Nordisk's operating profit increased by 9% in Danish kroner and by 8% at..
GL
08/05NOVO NORDISK A/S : Disclosure of transaction data
PU
07/28NOVO NORDISK A/S : – Share repurchase programme
AQ
07/28NOVO NORDISK A/S : Disclosure of transaction data
PU
07/20NOVO NORDISK A/S : Disclosure of transaction data
PU
07/20NOVO NORDISK A/S : Share repurchase programme
PU
07/13NOVO NORDISK A/S : Disclosure of transaction data
PU
07/13NOVO NORDISK A/S : – Share repurchase programme
AQ
07/02UNIVERSITY OF COPENHAGEN : Major antibody trial will determine whether the immun..
AQ
06/29NOVO NORDISK A/S : – Share repurchase programme
AQ
06/29Rybelsus® approved in Japan for the treatment of type 2 diabetes
GL
06/24NOVO NORDISK A/S : - Share repurchase programme
AQ
06/21NOVO NORDISK A/S : First Circuit Rules On Post-employment Restrictions As COVID-..
AQ
06/18Novo Nordisk successfully completes AM833 phase 2 trial and phase 1 combinati..
GL
06/17DTU : Engineers put DTU at forefront of research and development
AQ
06/16NOVO NORDISK A/S : Courts Across The Country Continue To Address Trade Secrets I..
AQ
06/15NOVO NORDISK A/S : - Semaglutide 2.4 mg shows superior weight loss versus placeb..
AQ
06/15NOVO NORDISK A/S : – Share repurchase programme
AQ
06/12Semaglutide 2.4 mg shows superior weight loss versus placebo in the phase 3 t..
GL
06/11NOVO NORDISK A/S : to acquire Corvidia Therapeutics and expand presence in cardi..
PU
06/05NOVO NORDISK A/S : reports weight loss of 14.9% in STEP 1 trial
AQ
06/04NOVO NORDISK A/S : reports weight loss of 14.9% (16.9% if taken as intended) in ..
AQ
06/04Novo Nordisk reports weight loss of 14.9% (16.9% if taken as intended) in STE..
GL
06/03NOVO NORDISK A/S : - EU-supported international research project aims to improve..
AQ
06/03NOVO NORDISK A/S : – Share repurchase programme
AQ
06/02NOVO NORDISK A/S : EU-supported international research project aims to improve o..
AQ
06/01NOVO NORDISK A/S : Basilea announces appointment of new Head of Global Quality M..
AQ
05/29NOVO NORDISK A/S : MIT - New technology enables fast protein synthesis
AQ
05/27NOVO NORDISK A/S : launches new social responsibility strategy to defeat diabete..
PU
05/25NOVO NORDISK A/S : – Share repurchase programme
AQ
05/13Semaglutide 2.4 mg demonstrates superior and sustained weight loss versus pla..
GL
05/12Ascendis Pharma A/S Will Appoint Jesper Hoiland as Global Chief Commercial Of..
AQ
05/12NOVO NORDISK A/S : Trading in Novo Nordisk shares by board members, executives a..
AQ
05/11Novo Nordisk A/S
PU
05/11Novo Nordisk A/S
AQ
05/11NOVO NORDISK A/S : Share repurchase programme
PU
05/11NOVO NORDISK A/S : purchases B shares worth DKK 3,051 million from Novo Holdings..
AQ
05/11NOVO NORDISK A/S : Trading in Novo Nordisk shares by board members, executives a..
AQ
05/06NOVO NORDISK : 1Q Earnings Snapshot
AQ
05/06Novo Nordisk's sales increased by 16% in Danish kroner and by 14% at constant..
GL
05/05NOVO NORDISK A/S : – Share repurchase programme
AQ
05/04EXPRES2ION BIOTECH PUBL : announces supporting an advantageous COVID-19 diagnost..
AQ
04/28NOVO NORDISK A/S : - Articles of Association
AQ
04/28Novo Nordisk A/S – Reduction of the share capital
GL
04/27NOVO NORDISK A/S : Share repurchase programme
PU
04/20NOVO NORDISK A/S : – Share repurchase programme
AQ
04/14NOVO NORDISK A/S : Lost insurance & need insulin? Makers offer it free or cheap
AQ
04/06NOVO NORDISK A/S : Share repurchase programme
PU
04/06NOVO NORDISK A/S : - Rybelsus approved for the treatment of adults with type 2 d..
AQ
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on NOVO NORDISK A/S